Clinical Trials · NCT07284511
A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
- Phase
- Phase 2/Phase 3
- Recruitment status
- Recruiting
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Enrollment
- 105
- Start date
- May 2026
- Locations
- 4 sites, Canada, Switzerland
- Primary endpoint
- Daytime Time-in-Range